Skip to main content
letter
. 2024 Apr 20;12(1):e41. doi: 10.22037/aaem.v12i1.2233

Table 1.

Comparing the baseline characteristics of patients between groups

Variable Groups P-Value
Vit C (n=105) Control (n=105)
Sex
Male 52 (49.5) 66 (62.9) 0.052
Female 53 (50.5) 39 (37.1)
Age (year)
Median (IQR) 60 (48 - 67.5) 65 (51 - 75) 0.068
Comorbidities
No 52 (49.5) 39 (37.1) 0.197
Diabetes mellitus 4 (3.8) 6 (5.7)
Hypertension 13 (12.4) 20 (19)
Hyperlipidemia 0 (0) 1 (1)
Ischemic Heart Disease 4 (3.8) 2 (1.9)
Immune disorder 4 (3.8) 1 (1)
Rheumatoid Arthritis 1 (1) 0 (0)
Cancer 2 (1.9) 4 (3.8)
Chronic Kidney Disease 0 (0) 3 (2.9)
Other* 25 (23.8) 29 (27.6)
Past medical history
Corticosteroid 5 (4.8) 3 (2.9) 0.145
Chemotherapy 0 (0) 4 (3.8)
No 100 (95.2) 98 (93.3)
APACHE
Median (IQR) 14 (10 - 20) 16 (11 - 23) 0.055
Duration of hospitalization
Median (IQR) 5 (4 - 9) 5 (3 - 7) 0.111
Habit
Smoker 4 (3.8) 4 (3.8) 1.000
Alcohol 1 (1) 4 (3.8) 0.369
Vaccinated
Yes 3 (2.9) 2 (1.9) 1.000
No 102 (97.1) 103 (98.1)
laboratory findings (admission to ICU)
D-Dimer 2135 (957.5 - 5387.5) 1810 (828.5 - 4693.5) 0.397
CRP 75 (36.5 - 132) 95 (47 - 146.5) 0.025
Lactate dehydrogenase 870 (534.5 - 1209.5) 690 (495.5 -1245.5) 0.280
Ferritin 663 (455 - 790) 760 (522.5 - 926) 0.087
ESR 40 (20.5 - 55) 45 (20.25 - 66.5) 0.347
O2 saturation (%)
Median (IQR) 83 (72 - 89.5) 80 (70 - 89.5) 0.591
Lung involvement (%)
Median (IQR) 70 (50 - 80) 70 (50 - 80) 0.418

Data are presented as frequency (%) or median (interquartile range (IQR)). *Other diseases in each disease group were so small and rare that they are not listed separately in the table. ESR: Erythrocyte sedimentation rate; CRP: C-reactive protein; ICU: intensive care unit.